Revvity (NYSE:RVTY) Stock Sold by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Revvity stock on September 3rd.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Revvity Stock Performance

Shares of Revvity stock traded down $1.55 during mid-day trading on Wednesday, hitting $153.53. 595,948 shares of the stock were exchanged, compared to its average volume of 1,500,820. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $166.25. The company has a market capitalization of $17.13 billion, a P/E ratio of 73.03, a P/E/G ratio of 2.83 and a beta of 1.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The company has a 50-day simple moving average of $134.17 and a 200 day simple moving average of $112.19.

Revvity (NYSE:RVTY) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same period last year, the firm posted $1.18 earnings per share. Revvity’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Sell-side analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio is presently 13.33%.

Analyst Ratings Changes

A number of brokerages recently weighed in on RVTY. Weiss Ratings raised Revvity from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. TD Cowen upped their price target on Revvity from $130.00 to $175.00 and gave the stock a “buy” rating in a report on Tuesday. Royal Bank Of Canada began coverage on shares of Revvity in a research note on Tuesday, September 1st. They issued a “sector perform” rating and a $135.00 price target on the stock. William Blair initiated coverage on shares of Revvity in a report on Monday, October 5th. They issued an “outperform” rating for the company. Finally, Barclays boosted their price target on Revvity from $115.00 to $160.00 and gave the company an “equal weight” rating in a report on Wednesday, October 7th. Five equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $124.43.

Insider Activity at Revvity

In related news, insider Tajinder Vohra sold 7,330 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the transaction, the insider directly owned 6,635 shares in the company, valued at $934,738.80. The trade was a 52.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Maxwell Krakowiak sold 1,631 shares of the stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $144.53, for a total transaction of $235,728.43. Following the completion of the sale, the insider directly owned 14,781 shares of the company’s stock, valued at $2,136,297.93. This represents a 9.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 9,130 shares of company stock valued at $1,290,745 over the last quarter. Company insiders own 0.85% of the company’s stock.

Hedge Funds Weigh In On Revvity

Several institutional investors have recently added to or reduced their stakes in RVTY. Jupiter Topco LLC bought a new stake in Revvity during the 2nd quarter valued at $961,017,000. BlackRock Inc. purchased a new position in Revvity during the 2nd quarter valued at about $852,070,000. Janus Henderson Group PLC raised its stake in Revvity by 7.0% in the fourth quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock valued at $789,595,000 after purchasing an additional 533,912 shares in the last quarter. EdgePoint Investment Group Inc. grew its position in Revvity by 3.1% during the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock valued at $771,044,000 after acquiring an additional 265,204 shares during the last quarter. Finally, State Street Corp increased its stake in Revvity by 0.8% in the 2nd quarter. State Street Corp now owns 4,342,739 shares of the company’s stock worth $483,173,000 after purchasing an additional 32,426 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Revvity Company Profile

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.